ProMIS Neurosciences shareholders approve stock issuance for warrants at special meeting

ProMIS Neurosciences Inc.

Proposal 1 (stock issuance for warrants) passed with 8,948,590 votes for, 121,116 against, 23,726 abstain.
Proposal 2 (adjournment) passed with 8,973,770 votes for, 116,190 against, 3,472 abstain; deemed unnecessary due to quorum.
Votes relate to warrants issued in private placement closed July 31, 2024, to comply with Nasdaq Listing Rule 5635(d).
No other matters were submitted to or voted on at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.